sb 203580 has been researched along with Kidney Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, A; Mishra, SP; Ojha, R; Semwal, DK; Semwal, RB | 1 |
| Du, ZX; Gao, YY; Guan, Y; Liu, BQ; Meng, X; Wang, HQ; Zhang, HY | 1 |
| Han, YH; Kim, SH; Kim, SZ; Moon, HJ; Park, WH; You, BR | 1 |
3 other study(ies) available for sb 203580 and Kidney Neoplasms
| Article | Year |
|---|---|
Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Kidney Neoplasms; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Sirolimus; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2017 |
Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression.
Topics: Adaptor Proteins, Signal Transducing; Anthracenes; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Leupeptins; Mitogen-Activated Protein Kinase 8; p38 Mitogen-Activated Protein Kinases; Proteasome Inhibitors; Pyridines; Signal Transduction | 2009 |
p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Topics: Animals; Antimycin A; Cell Cycle; Cell Death; Cell Growth Processes; Cell Line, Tumor; Flavonoids; Glutathione; Imidazoles; Juxtaglomerular Apparatus; Kidney Neoplasms; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Reactive Oxygen Species | 2009 |